טוען...
Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
BACKGROUND: The aim of this study is to analyze mortality in patients treated with bevacizumab for wet AMD. METHODS: We conducted a retrospective case-control study between patients who received intravitreal injections of bevacizumab as the sole treatment for exudative AMD between September 2008 and...
שמור ב:
| הוצא לאור ב: | BMC Ophthalmol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5635499/ https://ncbi.nlm.nih.gov/pubmed/29017506 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-017-0586-0 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|